News for 'Ajanta Company'

Abbott Bets On Semaglutide Boom

Abbott Bets On Semaglutide Boom

Rediff.com28 Feb 2026

Abbott will exclusively distribute and market Extensior in the country, becoming the second company to secure sole distribution rights for Novo's semaglutide portfolio in India, after Emcure Pharma.

Ajanta wallclock maker bagged the Morbi bridge maintenance deal

Ajanta wallclock maker bagged the Morbi bridge maintenance deal

Rediff.com31 Oct 2022

The Oreva group, which is under the scanner following the collapse of the suspension bridge at Morbi in Gujarat that killed at least 130 people, specialises in CFL bulbs, wall clocks and e-bikes, and it is not known how it managed to get the contract to maintain an over 100-year-old bridge.

Ajanta Pharma reissues shares

Ajanta Pharma reissues shares

Rediff.com1 Mar 2003

Ajanta Pharma Ltd reissued 250 equity shares, earlier forfeited by the company.

Ajanta forays into FMCG sector

Ajanta forays into FMCG sector

Rediff.com6 Jan 2004

Watchmaker Ajanta India Ltd has forayed into the fast-moving consumer goods sector with a gamut of consumer care products and expected to close the current fiscal with a turnover of Rs 120 crore.

Chappal ad used her image; Mamata livid

Chappal ad used her image; Mamata livid

Rediff.com24 Jun 2010

The full page advertisement that claims that Mamata was wearing rubber slippers manufactured by Ajanta Company, was published in June 21 edition in Sambad Pratidin, a Kolkata-based Bengali newspaper.

Ajanta Pharma, Medicago join hands for flu vaccine

Ajanta Pharma, Medicago join hands for flu vaccine

Rediff.com21 Aug 2009

Mumbai-based Ajanta Pharma has tied up with the Canadian vaccine maker, Medicago Inc, to commercialise Medicago's pandemic and seasonal influenza vaccines in India and other territories.

Lower input costs may aid pharma firms' Q2 margins

Lower input costs may aid pharma firms' Q2 margins

Rediff.com21 Oct 2024

Analysts are expecting pharmaceutical companies to post sales growth of 10-11 per cent in the second quarter this financial year while the Ebitda (earnings before interest, tax, depreciation, and amortisation) margins are anticipated to improve by about 110 basis points. Ebitda improvement will be led by lower input costs because prices of active pharmaceutical ingredients (APIs) are 5-15 per cent lower year-on-year (Y-o-Y). Axis Capital said sales growth would be around 10 per cent, of which growth in the India market would be 11 per cent or so.

HC raps Morbi civic body for allowing public to use 'critical' bridge

HC raps Morbi civic body for allowing public to use 'critical' bridge

Rediff.com16 Nov 2022

The HC sought the information from the Morbi municipality while hearing a suo motu (on its own) public interest litigation on the collapse of the bridge.

Check The Management Before Investing

Check The Management Before Investing

Rediff.com12 Feb 2024

A lot depends upon the crucial decision-making skills of the management. If you have any doubts about the management then you always have the choice of selling your shares or not buying stocks of those companies at all.

Firm given task to repair Morbi bridge, reopened without nod: Civic body to HC

Firm given task to repair Morbi bridge, reopened without nod: Civic body to HC

Rediff.com17 Nov 2022

The civic body submitted the affidavit before a division bench of Chief Justice Aravind Kumar and Justice Ashutosh Shastri which is hearing a suo motu (on its own) case on the collapse of the bridge.

Largecap, midcap cutoff surges over 26% in latest Amfi classification

Largecap, midcap cutoff surges over 26% in latest Amfi classification

Rediff.com12 Jan 2024

The rally in the equity markets in the second half of 2023 has led to a sharp surge in the cutoff for stocks to qualify as largecaps and midcaps. On the latest list put out by the Association of Mutual Funds in India (Amfi), the smallest largecap stock now has a market capitalisation (m-cap) of Rs 67,000 crore, 35 per cent higher than in July 2023. In the case of midcaps, the cutoff has surged 26 per cent to Rs 22,000 crore.

Gujarat HC asks govt how Morbi bridge upkeep largesse went to Oreva

Gujarat HC asks govt how Morbi bridge upkeep largesse went to Oreva

Rediff.com15 Nov 2022

The Gujarat high court on Tuesday heard a suo motu public interest litigation (PIL) on Morbi bridge tragedy and asked the state government as to how no expression of interest was tendered, and how the 'largesse of the state' was given to an individual without floating a tender.

Serious lapses by Oreva led to Morbi bridge tragedy: SIT report in HC

Serious lapses by Oreva led to Morbi bridge tragedy: SIT report in HC

Rediff.com10 Oct 2023

The lackadaisical approach on part of the management of Oreva company resulting in "one of the most severe and tragic human calamities" cannot be countenanced, the SIT said.

A year on, kin of Morbi bridge victims still seek 'justice'

A year on, kin of Morbi bridge victims still seek 'justice'

Rediff.com30 Oct 2023

Apart from the 10 persons arrested so far, those found guilty of negligence in the Special Investigation Team (SIT) report should also be arrested and punished, said a man who lost his 10-year-old daughter in the tragedy.

Morbi bridge collapse: Oreva Group MD sent to custody

Morbi bridge collapse: Oreva Group MD sent to custody

Rediff.com8 Feb 2023

Patel, whose company was responsible for the operation and maintenance of the bridge, surrendered before the court on January 31 after it issued an arrest warrant against him. He was later arrested by the police.

Oreva group offers compensation to Morbi victims, HC says it won't be let off

Oreva group offers compensation to Morbi victims, HC says it won't be let off

Rediff.com25 Jan 2023

The Gujarat high court agreed to the Oreva group's offer on Wednesday to pay compensation to the victims of the Morbi bridge collapse that left 135 dead and several injured but said it will "not absolve it of any liability".

Morbi bridge collapse: Oreva MD Jaysukh Patel sent to 7-day police custody

Morbi bridge collapse: Oreva MD Jaysukh Patel sent to 7-day police custody

Rediff.com1 Feb 2023

Chief Judicial Magistrate MJ Khan sent Patel in the custody of the special investigation team formed by the state government to probe the case till February 8.

India business to put a spring in pharma's step

India business to put a spring in pharma's step

Rediff.com26 Apr 2023

Hospitals to recover from sluggish Q3; diagnostics' growth rate at pre-Covid levels.

Morbi bridge collapse: Oreva Group MD surrenders, sent to jail

Morbi bridge collapse: Oreva Group MD surrenders, sent to jail

Rediff.com31 Jan 2023

Ajanta Manufacturing Limited (Oreva Group) was responsible for the operation and maintenance of the British-era suspension bridge on the Machchhu river in Morbi that collapsed on October 30 last year, days after its repairs.

Travel Quiz: How Well Do You Know India?

Travel Quiz: How Well Do You Know India?

Rediff.com8 Feb 2023

If you consider yourself a passionate India traveller, have a go at this quiz on fallen-off-the-map places to visit in our country.

Is my portfolio good?'

Is my portfolio good?'

Rediff.com31 Jan 2022

Ajit Mishra, vice president, research, Religare Broking, answers your queries.

BSE drops Tata Power from Sensex; Lupin to come in

BSE drops Tata Power from Sensex; Lupin to come in

Rediff.com22 May 2015

Adani Power will also be dropped from the S&P BSE 100 index

Corporates refute Volcker charge

Corporates refute Volcker charge

Rediff.com31 Oct 2005

Brand-conscious firms ramp up IPR protection

Brand-conscious firms ramp up IPR protection

Rediff.com11 Jun 2007

Even as conflicts between rival brands increase in India, industry experts find the trend encouraging.

How investors can fetch exceptional returns

How investors can fetch exceptional returns

Rediff.com10 Dec 2016

TCS tops the list of 100 wealth creators for the fourth time in a row

TCS, ITC biggest wealth creators during 2010-15

TCS, ITC biggest wealth creators during 2010-15

Rediff.com11 Dec 2015

TCS created wealth worth Rs 3,458 billion for the period 2010-15.

'Make in Maharashtra' receives good response from China, says CM

'Make in Maharashtra' receives good response from China, says CM

Rediff.com19 May 2015

CM makes 'Make in Maharashtra' pitch to China.

BSE Midcap index set for worst monthly fall in 18 months

BSE Midcap index set for worst monthly fall in 18 months

Rediff.com1 Jun 2018

The BSE Midcap index has declined 5.7% thus far in May 2018. In comparison, the S&P BSE Small-cap index has lost 5.6%

How was private entity given mandate to maintain Red Fort, asks Congress

How was private entity given mandate to maintain Red Fort, asks Congress

Rediff.com28 Apr 2018

The Dalimia Bharat group, under the memorandum of understanding, would maintain the monument and build basic infrastructure around it and has committed a sum of Rs 25 crore for the purpose over a period spanning five years.

Ask Ajit: Stocks to BUY, HOLD or SELL

Ask Ajit: Stocks to BUY, HOLD or SELL

Rediff.com18 Aug 2021

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Drugs ban: Partial relief for Wockhardt, Glaxo & Griffon

Drugs ban: Partial relief for Wockhardt, Glaxo & Griffon

Rediff.com18 Mar 2016

The Delhi High Court on Friday stayed the ban on some fixed dose combination (FDC) drugs of Glaxo SmithKline, Wockhardt and Laboratories Griffon but said action against their sale could be taken in the absence of valid sale and marketing licence.

Note ban shadow lingers over one in four BSE 200 stocks

Note ban shadow lingers over one in four BSE 200 stocks

Rediff.com30 Mar 2017

Quite a few large- and mid-cap stocks are yet to recover from the note ban, pharma, banking and rural demand-based industries among laggards.

Mid-cap selloff: Don't press the panic button, say experts

Mid-cap selloff: Don't press the panic button, say experts

Rediff.com7 Jun 2017

Despite the recent fall, the Nifty Midcap 100 index has outperformed by gaining 20 per cent till date in this year calendar year.

Mid-cap selloff: Don't press the panic button, say experts

Mid-cap selloff: Don't press the panic button, say experts

Rediff.com7 Jun 2017

Despite the recent fall, the Nifty Midcap 100 index has outperformed by gaining 20 per cent till date in this year calendar year.

Markets end flat; Commodity stocks rally

Markets end flat; Commodity stocks rally

Rediff.com8 Mar 2016

Bank shares were the top losers after sharp gains last week.

'Can't book profits in stock markets. Need help'

'Can't book profits in stock markets. Need help'

Rediff.com7 Dec 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

ASK AJIT: Stocks to hold or exit

ASK AJIT: Stocks to hold or exit

Rediff.com8 Dec 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Tips to pick the right stocks and make big gains

Tips to pick the right stocks and make big gains

Rediff.com14 Sep 2015

Raamdeo's base argument is that India's stock market merely mirrors the national economy, which is poised for big things.